Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
Serum M2BPGi level is a novel predictive biomarker for the responses to pegylated interferon-α treatment in HBeAg-positive chronic hepatitis B patients. [electronic resource] by
- Zhu, Ming-Yu
- Chen, Pei-Zhan
- Li, Jing
- Yu, De-Min
- Huang, Dao
- Zhu, Xue-Juan
- Han, Yue
- Chen, Jie
- Huang, Wei
- Chen, Yong-Yan
- Gong, Qi-Ming
- Jiang, Jie-Hong
- Zhang, Dong-Hua
- Zhang, Yan
- Zhang, Ji-Ming
- Zhang, Xin-Xin
Producer: 20190401
In:
Journal of medical virology vol. 90
Availability: No items available.
|